AnaptysBio Inc Stock
Price
Target price
€38.00
€38.00
1.600%
0.6
1.600%
€46.41
09.01.26 / Frankfurt
WKN: A2AJ8C / Symbol: ANAB / Name: AnaptysBio / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for AnaptysBio
sharewise wants to provide you with the best news and tools for AnaptysBio, so we directly link to the best financial data sources.
Financials
News
What This Insider Trim at AnaptysBio Means for Investors After a 260% Stock Rally
On Dec. 23, AnaptysBio (NASDAQ:ANAB) Director J. Anthony Ware executed an open-market sale of 3,900 shares for a transaction value of $193,342.50, representing 28.82% of his direct holdings
What Investors Should Know About a $163K AnaptysBio Insider Sale
Paul F. Lizzul, the chief medical officer of AnaptysBio (NASDAQ:ANAB), reported the direct sale of 3,650 shares of the company for a total consideration of approximately $163,191.50 on Thursday, as
AnaptysBio (ANAB) Q2 Revenue Jumps 103%
AnaptysBio (NASDAQ:ANAB), a clinical-stage biotechnology company focused on innovative immunology therapeutics for autoimmune and inflammatory diseases, released its Q2 2025 earnings on August 6